← All trials
NCT06988475
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Nov 19, 2024
- Primary completion
- Oct 31, 2029
- Completion date
- Oct 31, 2029
- First posted
- May 23, 2025
- Last posted
- Nov 24, 2025
- Enrollment
- 30
- Arms / groups
- 1 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Cancer Research UKLead sponsor
- Royal Marsden Hospital NHS TrustCollaborator
- The Christie NHS Foundation TrustOfficial
- University of BirminghamCollaborator
- University of ManchesterCollaborator
- NovartisCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.